JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, M.
Right arrow Articles by Chen, S. R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, M.
Right arrow Articles by Chen, S. R. W.

J Biol Chem, Vol. 274, Issue 37, 25971-25974, September 10, 1999

COMMUNICATION
Molecular Identification of the Ryanodine Receptor Pore-forming Segment*

Mingcai ZhaoDagger §, Pin LiDagger §, Xiaoli LiDagger , Lin ZhangDagger , Robert J. Winkfein, and S. R. Wayne ChenDagger parallel

From the Dagger  Cardiovascular Research Group, Department of Physiology and Biophysics, and Department of Biochemistry and Molecular Biology, and the  Medical Research Council Group on Ion Channels and Transporters, University of Calgary, Calgary, Alberta T2N 4N1, Canada

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

A sequence motif, GXRXGGGXGD, located in the putative channel-forming domain, is conserved in all known ryanodine receptors and inositol 1,4,5-trisphosphate receptors. The functional significance of this conserved region was investigated by using site-directed mutagenesis together with functional assays consisting of Ca2+ release measurements, [3H]ryanodine binding, and single channel recordings in planar lipid bilayers. We report here that single point mutations introduced into this region of the mouse cardiac ryanodine receptor reduce or abolish high affinity [3H]ryanodine binding. Single channel analysis revealed that a single substitution of alanine for glycine 4824 within this region reduced the single channel conductance by 97%, from 798 picosiemens (pS) for the wild type channel to 22 pS. The G4824A mutant channel was modulated by Ca2+, Mg2+, ATP, caffeine, ruthenium red, and ryanodine. Co-expression of the wild type and G4824A mutant proteins produced single channels that have intermediate unitary conductances of 516, 256, 176, and 60 pS. These data suggest that this conserved region constitutes an essential part of the ryanodine binding site and the channel conduction pathway of the ryanodine receptor.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Ryanodine receptors (RyRs)1 are members of a superfamily of intracellular Ca2+ channels that include the inositol 1,4,5-trisphosphate receptors (IP3Rs). These channels play an essential role in intracellular Ca2+ signaling by virtue of releasing Ca2+ from the lumen of sarco(endo)plasmic reticulum to the cytosol of muscle and non-muscle cells (1, 2).

RyR is a homotetrameric structure composed of four identical subunits, each having ~5000 amino acids. Sequence analysis reveals that one-fifth of the COOH terminus of the molecule is likely to form the channel conducting pore. The remaining ~4000 amino acid residues apparently constitute the cytoplasmic "foot" domain (3-7). A truncated RyR in which the foot domain has been deleted has been shown to function as a Ca2+ release channel. The truncated RyR channel was still regulated by Ca2+, was modified by ryanodine, and exhibited a single channel conductance similar to that of the full-length RyR (8). These studies indicate that the sites for Ca2+ activation and ryanodine binding, and the ion conduction pathway are located within the COOH-terminal ~1000 amino acid residues. A glutamate residue located in the putative transmembrane sequence M2 has recently been identified as the Ca2+ sensor of RyR (9). The locations of the ryanodine binding site and the pore-forming segment of RyR, however, have yet to be defined.

RyRs and IP3Rs share some sequence homology, in particular in the COOH-terminal channel-forming domain (10). Considering their sequence homology and similar conduction properties (11-13), RyRs and IP3Rs are likely to share similar structural features in the channel pore. A hydrophobic region between the M5 and M6 transmembrane sequences of the mouse type 1 IP3R has been proposed to be the pore-forming region (14). The equivalent region in RyR, corresponding to the M9 transmembrane sequence proposed by Zorzato et al. (15), is also hydrophobic. Sequence alignment of these regions reveals a GXRXGGGXGD motif that can be found in all known RyRs and IP3Rs (Fig. 1). To investigate its role in RyR function, we have introduced point mutations into this highly conserved region and examined the functional consequences of these point mutations. Our data indicate that this region is critical for ryanodine binding and ion conduction and probably constitutes the pore-forming segment of RyRs.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Materials-- Ryanodine was obtained from Calbiochem. [3H]Ryanodine was from NEN Life Science Products. Monoclonal antibody 34C was a generous gift from Dr. John L. Sutko (16).

Cloning of the Mouse Cardiac RyR cDNA-- Total RNA from mouse heart tissue, isolated by the method of Chomczynski and Sacchi (17), was used to generate first strand cDNA using the SuperScript Preamplification System (Life Technologies, Inc.) with random primers. Using degenerate primers designed on the basis of the reported cDNA sequences of the rabbit (18, 19) and human (20) cardiac RyR, we obtained six short PCR fragments corresponding to nucleotides 1171-1661, 3286-3821, 5689-6256, 11029-11646, 13366-13599, and 13473-14919 of the mouse cardiac RyR (mRyR2) cDNA. These cDNA fragments were then used as probes to screen a mouse cardiac cDNA library. Four overlapping clones, corresponding to nucleotides 5'-UTR-6486, 1891-8268, 7602-13,359, and 12,991-3'-UTR, covering the entire coding region and part of the 5'- and 3'-untranslated regions of the mRyR2, were obtained. These overlapping clones were used to construct the full-length mRyR2 cDNA in the expression vector pCDNA3 (Invitrogen) for functional expression studies.

Site-directed Mutagenesis-- Point mutations were carried out by the overlap extension method (21) using the PCR. The NruI (14,237)-NotI (vector) cDNA fragment that contains the 3' end of the mRyR2 cDNA was subcloned into the pBluescript vector and was used as a template for site-directed mutagenesis. PCR products were subcloned into pBluescript and the sequence of each PCR clone was confirmed by DNA sequencing. The NruI (14,237)-NotI (vector) fragment was removed from the PCR clone and subcloned into the full-length mRyR2 cDNA. Transfection of HEK293 cells were carried out using Ca2+ phosphate precipitation.

Ca2+ Release Measurements-- Free cytosolic Ca2+ concentration in transfected HEK293 cells was measured with the fluorescence Ca2+ indicator dye fluo-3 as described previously (9).

[3H]Ryanodine Binding-- Equilibrium [3H]ryanodine binding to cell lysates was carried out using the method described by Du et al. (22).

RyR Purification and Single Channel Recordings-- Recombinant wild type and mutant mRyR2 proteins were purified from cell lysates by sucrose density gradient centrifugation as described previously (23). Single channel recordings were carried out using CHAPS-solubilized and sucrose density gradient-purified wild type and mutant recombinant mRyR2 proteins as reported previously (23). Free Ca2+ concentrations were calculated using the computer program of Fabiato and Fabiato (24).

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

We first investigated the functional consequences of single point mutations in the putative pore-forming segment (Fig. 1) by measuring caffeine-induced Ca2+ release in HEK293 cells transfected with the wild type and various mutant cDNAs. Addition of 2 mM caffeine resulted in an increase in the fluo-3 fluorescence in cells transfected with the wild type and all mutant cDNAs, but not in cells transfected with the vector DNA (Fig. 2a). These data demonstrate that all mutants can function as Ca2+ release channels. To further characterize these mutants, we carried out [3H]ryanodine binding. Fig. 2b shows that mutations at R4822, G4825, G4828, and D4829 reduced or abolished high affinity [3H]ryanodine binding, while caffeine-induced Ca2+ release from these mutants was comparable with that from the wild type. On the other hand, mutation at G4824 retained [3H]ryanodine binding, but decreased caffeine-induced Ca2+ release. Mutations at G4820 and G4826 reduced caffeine-induced Ca2+ release and abolished [3H]ryanodine binding. It should be noted that the levels of expression of the wild type and mutant RyR proteins were similar as revealed by immuno blotting (Fig. 2b). These data indicate that this conserved region is critical for ryanodine binding and channel function.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   A schematic diagram of transmembrane domains of RyR and IP3R. Ten transmembrane sequences (M1 to M10) have been predicted for RyR (15) and six (M1 to M6) for IP3R (14). The location of each transmembrane segment is depicted by a solid box. The shaded box indicates the location of the putative pore-forming segment (P) in IP3R. The amino acid sequence of this putative pore-forming segment and the sequence of the equivalent region of mRyR2 are shown by single letter amino acid codes. The solid circles indicate amino acid residues that are conserved in all known RyRs and IP3Rs and were mutated in this study.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of point mutations on intracellular Ca2+ release in transfected HEK293 cells (A) and on [3H]ryanodine binding (B). A, HEK293 cells were transfected with 6 µg of wild type (WT) cDNA; 6 µg of mutant (G4820A, R4822A, G4824A, G4825A, G4826A, G4828A, or D4829A) cDNA; or 6 µg of pCDNA3 vector DNA. Fluorescence intensity of fluo 3-loaded cells was measured before and after addition of 2 mM caffeine (solid circles). B, [3H]ryanodine binding was carried out in the presence of 0.5 mM EGTA and 0.8 mM CaCl2. Data shown are mean ± average error from three separate experiments. The bottom panel shows an immunoblot (23) of cell lysates (10 µl) prepared form HEK293 cells transfected with 12 µg of wild type (WT) cDNA, various mutant cDNAs, or pCDNA3 using the anti-RyR monoclonal antibody 34C.

Ryanodine binds to RyRs in an open state with high affinity. The binding of ryanodine modifies channel gating and ion conduction and reduces single channel conductance of RyRs (3-7, 25). The significance of this region in ion conduction was examined by determining the effect of these mutations on single channel conductance. Fig. 3a shows single channel recordings of the wild type and mutant G4824A channels after incorporating into planar lipid bilayers at different holding potentials. The unitary conductance of the mutant G4824A channel, determined in symmetrical 250 mM KCl, was 22 ± 1.1 pS (n = 4), compared with 798 ± 17 pS (n = 3) for the wild type channels. Thus, the G4824A mutation reduced the single channel conductance of mRyR2 by 97%. To examine whether the G4824A mutant channel is still sensitive to modulators of RyR, we assessed the effects of various ligands on single channel activity and [3H]ryanodine binding. The mutant channel was activated by ATP and caffeine, was inhibited by MgCl2, and was modified by ryanodine (Fig. 3b). [3H]Ryanodine binding to mutant G4824A was also activated by ATP, caffeine, and Ca2+ and was inhibited by MgCl2, ruthenium red, and EGTA (Fig. 3c). A similar extent of modulation by these ligands on [3H]ryanodine binding (Fig. 3c) and single channel activity (not shown) was also observed with the wild type channel. Thus, the specific effect of G4824A mutation on single channel conductance and the critical role of residues flanking this glycine in high affinity ryanodine binding suggest that this region is involved in the formation of the channel conducting pore.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of G4824A mutation on single channel function and [3H]ryanodine binding. a, single channel activities of the wild type (WT) (A) and G4824A mutant (B) mRyR2 channels were recorded in a symmetrical recording solution containing 250 mM KCl and 25 mM Hepes (pH 7.4). The holding potentials are shown on the left, and base lines are indicated by a short line to the right of each current trace. Current-voltage (I-V) relationships of the wild type (C) and G4824A mutant (D) are shown. b, a single mutant G4824A channel was inhibited by the addition of 100 µM EGTA (cis) (not shown), indicating that the channel was incorporated into the bilayer with its cytoplasmic side facing the cis chamber. All subsequent additions were then made to the cis (cytoplasmic) chamber. Single channel current recordings in the presence of 127 nM free Ca2+, and after sequential additions (cis) of 2 mM ATP and 2 mM caffeine were made from the same channel. Current recordings in the presence of 10 µM ryanodine were obtained from a different channel. Single channel activities shown in E (control) and F (after addition of 2 mM MgCl2) were recorded in the presence of 200 nM free Ca2+. The open probability (Po) at each condition is indicated on the top of each panel. The holding potential was +80 mV. C, [3H]ryanodine binding to the wild type and G4824A mutant mRyR2 was carried out in the presence of 120 nM free Ca2+ (Cont) or plus 2.5 mM ATP, 2.5 mM caffeine, 5 mM MgCl2, 30 µM ruthenium red, 2.5 mM EGTA, or 150 µM CaCl2. Data shown are mean ± average error from three separate experiments.

In potassium channels, the ion conduction pathway is formed by the pore-forming segments of each subunit (26, 27). To determine whether this is also the case for RyR, we co-expressed the wild type and mutant G4824A cDNA in a 1:1 ratio in HEK293 cells and determined the unitary conductance of each single channel observed. We expected that co-expression of the wild type and mutant channel would result in the formation of hybrid channels that contained different ratios of wild type and mutant subunits. These hybrid channels would exhibit certain conductance levels depending on the ratios of wild type and mutant subunits and the structural characteristics of the channel pore. We detected a total of 29 single channels, which can be separated into six groups according to their single channel conductances. Of the 29 single channels detected, one exhibited an unitary conductance of 778 pS, three 516 ± 4.3 pS, four 256 ± 14 pS, nine 176 ± 2.0 pS, eleven 60 ± 6.6 pS, and one 21 pS. All these single channels were sensitive to EGTA and Ca2+ and were modified by ryanodine (not shown). The 778- and 21-pS single channels probably represent the homotetrameric wild type and mutant G4824A channels, respectively, whereas single channels with intermediate unitary conductances are most likely represent the wild type-mutant hybrid channels. For example, the 516-pS conductance may be produced by a hybrid channel with three wild type and one mutant subunits, while the 60-pS conductance may be generated by a hybrid channel with three mutant and one wild type subunits. The 256- and 176-pS channels may be formed by two wild type and two mutant subunits with different subunit arrangements (Fig. 4a). It is of interest that these intermediate conductances can not be derived from a simple additive of the quarter conductance of the wild type (798/4 pS) and mutant (22/4 pS) in any possible ratios for a tetramer. Therefore, it is unlikely that the RyR channel conduction pathway is formed by four individual pores from each RyR subunit. Conversely, the glycines at position 4824 and the flanking residues of each monomer may act cooperatively to form the conduction pathway or the ion selectivity filter of the tetrameric RyR.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Co-expression of mutant G4824A produced single channels with intermediate conductances (a) and proposed model for the transmembrane topology and ion conduction pathway of RyR. a, HEK293 cells were transfected with 6 µg of wild type cDNA plus 6 µg of mutant G4824A cDNA. Single channel current fluctuations were recorded in symmetrical 250 mM KCl. Four distinct types of single channels with unitary conductances of 516 (A), 256 (B), 176 (C), and 60 pS (D) are shown. The holding potential was +40 mV. Base lines are indicated by a short line to the right of each current trace. Proposed subunit compositions and arrangements of hybrid channels for each observed conductance are indicated schematically on the right. Each circle represents a subunit of wild type or mutant G4824A. b, putative transmembrane segments (four or six) of RyR are depicted as open right cylinders. The remainder of the molecule is shown as the foot structure. The amino acid sequence of the proposed pore-forming segment (P segment), depicted as a loop inserted into the membrane, is shown in single amino acid codes. M8 and M10 (15) are likely to be the transmembrane sequences that flank the P segment. The sequences of the remaining two or four transmembrane segments have yet to be defined. A model for the ion conduction pathway of the tetrameric RyR, in which the P segments of each subunit form the channel pore similar to that of the potassium channels (26), is schematically shown at the bottom.

The equivalent region of other RyR isoforms (RyR1 and RyR3) and of IP3Rs is most likely to be important in determining the single channel conductance. To examine this possibility, we have mutated G4729 in RyR3, corresponding to G4824 in mRyR2, to alanine. The G4729A mutant RyR3 showed decreased caffeine-induced Ca2+ release and a drastic reduction in single channel conductance, but retained [3H]ryanodine binding, similar to those observed with the G4824A mutant mRyR2 (unpublished data). Recently, a mutation, I4898T, in RyR1, corresponding to I4827 in mRyR2, has been reported to be associated with severe central core disease (28). Introduction of this mutation into the rabbit RyR1 abolished [3H]ryanodine binding and caffeine or halothane-induced Ca2+ release in HEK293 cells transfected with the mutant cDNA. Co-expression of the wild type and mutant RyR1 cDNA in a 1:1 ratio produced RyR channels with normal caffeine and halothane sensitivities, but reduced levels of Ca2+ release and [3H]ryanodine binding (28). One explanation for these observations is that the I4849T mutation may disrupt the channel conduction pathway (29). Mutations near this isoleucine in RyR1 have also been reported to alter both [3H]ryanodine binding and single channel conductance (30). Taken together, we propose that this conserved region (GVRAGGGIGD) is likely to be the pore-forming segment of RyR, and that the pore-forming segments of each subunit constitute the RyR channel conduction pathway (Fig. 4b), analogous to the K+ channel pore (26).

    ACKNOWLEDGEMENTS

We thank Dr. John L. Sutko for the gift of the monoclonal antibody 34C, Dr. Jacques Barhanin for the gift of the mouse cardiac cDNA library, Dr. Wayne R. Giles and the Medical Research Council Group on Ion Channels and Transporters for continuous support, and Dr. Paul M. Schnetkamp for the use of his luminescence spectrometer.

    FOOTNOTES

* This work was supported by research grants from the Medical Research Council of Canada and the Alberta Heritage Foundation for Medical Research (to S. R. W. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this study.

parallel Scholar of the Alberta Heritage Foundation for Medical Research (AHFMR). To whom correspondence should be addressed. Tel.: 403-220-4235; Fax: 403-283-4841; E-mail: swchen@ucalgary.ca.

    ABBREVIATIONS

The abbreviations used are: RyRs, ryanodine receptors; IP3R, inositol 1,4,5-trisphosphate receptor; PCR, polymerase chain reaction; UTR, untranslated region; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; S, siemens.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve]
2. Clapham, D. E. (1995) Cell 80, 259-268[CrossRef][Medline] [Order article via Infotrieve]
3. Coronado, R., Morrissette, J., Sukhareva, M., and Vaughan, D. M. (1994) Am. J. Physiol. 266, C1485-C1504[Abstract/Free Full Text]
4. Meissner, G. (1994) Annu. Rev. Physiol. 56, 485-508[CrossRef][Medline] [Order article via Infotrieve]
5. Ogawa, Y. (1994) Crit. Rev. Biochem. Mol. Biol. 29, 229-274[Abstract]
6. Sorrentino, V. (1995) Adv. Pharmacol. 33, 67-90
7. Franzini-Armstrong, C., and Protasi, F. (1997) Physiol. Rev. 77, 699-729[Abstract/Free Full Text]
8. Bhat, M. B., Zhao, J., Takeshima, H., and Ma, J. (1997) Biophys. J. 73, 1329-1336[Abstract/Free Full Text]
9. Chen, S. R. W., Ebisawa, K., Li, X., and Zhang, L. (1998) J. Biol. Chem. 273, 14675-14678[Abstract/Free Full Text]
10. Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., and Mikoshiba, K. (1989) Nature 342, 32-38[CrossRef][Medline] [Order article via Infotrieve]
11. Bezprozvanny, I., and Ehrlich, B. E. (1994) J. Gen. Physiol. 104, 821-856[Abstract/Free Full Text]
12. Tinker, A., Lindsay, A. R. G., and Williams, A. J. (1992) J. Gen. Physiol. 100, 495-517[Abstract/Free Full Text]
13. Mak, D.-O. D., and Foskett, J. K. (1997) J. Gen. Physiol. 109, 571-587[Abstract/Free Full Text]
14. Michikawa, T., Hamanaka, H., Otsu, H., Yamamoto, A., Miyawaki, A., Furuichi, R., Tashiro, Y., and Mikoshiba, K. (1994) J. Biol. Chem. 269, 9184-9189[Abstract/Free Full Text]
15. Zorzato, F., Fujii, J., Otsu, K., Phillips, M., Green, N. M., Lai, F. A., Meissner, G., and MacLennan, D. H. (1990) J. Biol. Chem. 265, 2244-2256[Abstract/Free Full Text]
16. Airey, J. A., Beck, C. F., Murakami, K., Tanksley, S. J., Deerinck, T. J., Ellisman, M. H., and Sutko, J. L. (1990) J. Biol. Chem. 265, 14187-14194[Abstract/Free Full Text]
17. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[Medline] [Order article via Infotrieve]
18. Nakai, J., Imagawa, T., Hakamata, Y., Shigekawa, M., Takeshima, H., and Numa, S. (1990) FEBS Lett. 271, 169-177[CrossRef][Medline] [Order article via Infotrieve]
19. Otsu, K., Willard, H. F., Khanna, V. K., Zorzato, F., Green, N. M., and MacLennan, D. H. (1990) J. Biol. Chem. 265, 13472-13483[Abstract/Free Full Text]
20. Tunwell, R. E. A., Wickenden, C., Bertrand, B. M. A., Shevchenko, V. I., Walsh, M. B., Allen, P. D., and Lai, F. A. (1996) Biochem. J. 318, 477-487
21. Ho, S. N., Hunt, H. D., Morton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51-59[CrossRef][Medline] [Order article via Infotrieve]
22. Du, G. G., Imredy, J. P., and MacLennan, D. H. (1998) J. Biol. Chem. 273, 33259-33266[Abstract/Free Full Text]
23. Chen, S. R. W., Li, X., Ebisawa, K., and Zhang, L. (1997) J. Biol. Chem. 272, 24234-24246[Abstract/Free Full Text]
24. Fabiato, A., and Fabiato, F. (1979) J. Physiol. (Paris) 75, 463-505[Medline] [Order article via Infotrieve]
25. Tanna, B., Welch, W., Ruest, L., Sutko, J. L., and Williams, A. J. (1998) J. Gen. Physiol. 112, 55-69[Abstract/Free Full Text]
26. Doyle, D. A., Cabral, J. M., Pfeutzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R. (1998) Science 280, 69-77[Abstract/Free Full Text]
27. MacKinnon, R., Cohen, S. L., Kuo, A., Lee, A., and Chait, B. T. (1998) Science 280, 106-109[Abstract/Free Full Text]
28. Lynch, P. J., Tong, J., Lehane, M., Mallet, A., Giblin, L., Heffron, J. J. A., Vaughan, P., Zafra, G., MacLennan, D. H., and McCarthy, T. V. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4164-4169[Abstract/Free Full Text]
29. Balshaw, D., Gao, L., and Meissner, G. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3345-3347[Free Full Text]
30. Gao, L., Tripathy, A., Xu, L., Pasek, D., Balshaw, D., Xin, C., and Meissner, G. (1999) Biophys. J. 76, A303 (abstr.)


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Xu, Y. Wang, N. Yamaguchi, D. A. Pasek, and G. Meissner
Single Channel Properties of Heterotetrameric Mutant RyR1 Ion Channels Linked to Core Myopathies
J. Biol. Chem., March 7, 2008; 283(10): 6321 - 6329.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. T. Schug, P. C. A. da Fonseca, C. D. Bhanumathy, L. Wagner II, X. Zhang, B. Bailey, E. P. Morris, D. I. Yule, and S. K. Joseph
Molecular Characterization of the Inositol 1,4,5-Trisphosphate Receptor Pore-forming Segment
J. Biol. Chem., February 1, 2008; 283(5): 2939 - 2948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wang, W. Chen, S. Cai, J. Zhang, J. Bolstad, T. Wagenknecht, Z. Liu, and S. R. W. Chen
Localization of an NH2-terminal Disease-causing Mutation Hot Spot to the "Clamp" Region in the Three-dimensional Structure of the Cardiac Ryanodine Receptor
J. Biol. Chem., June 15, 2007; 282(24): 17785 - 17793.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev, April 1, 2007; 87(2): 593 - 658.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino
Central core disease is due to RYR1 mutations in more than 90% of patients
Brain, June 1, 2006; 129(6): 1470 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
L. Xu, Y. Wang, D. Gillespie, and G. Meissner
Two Rings of Negative Charges in the Cytosolic Vestibule of Type-1 Ryanodine Receptor Modulate Ion Fluxes
Biophys. J., January 15, 2006; 90(2): 443 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Liu, R. Wang, J. Zhang, S. R. W. Chen, and T. Wagenknecht
Localization of a Disease-associated Mutation Site in the Three-dimensional Structure of the Cardiac Muscle Ryanodine Receptor
J. Biol. Chem., November 11, 2005; 280(45): 37941 - 37947.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. M. Ranatunga, T. M. Moreno-King, B. Tanna, R. Wang, S. R. W. Chen, L. Ruest, W. Welch, and A. J. Williams
The Gln4863Ala Mutation within a Putative, Pore-Lining Trans-Membrane Helix of the Cardiac Ryanodine Receptor Channel Alters Both the Kinetics of Ryanoid Interaction and the Subsequent Fractional Conductance
Mol. Pharmacol., September 1, 2005; 68(3): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
Y. Wang, L. Xu, D. A. Pasek, D. Gillespie, and G. Meissner
Probing the Role of Negatively Charged Amino Acid Residues in Ion Permeation of Skeletal Muscle Ryanodine Receptor
Biophys. J., July 1, 2005; 89(1): 256 - 265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli
Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations
J. Biol. Chem., April 15, 2005; 280(15): 15380 - 15389.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
W. Welch, S. Rheault, D. J. West, and A. J. Williams
A Model of the Putative Pore Region of the Cardiac Ryanodine Receptor Channel
Biophys. J., October 1, 2004; 87(4): 2335 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
S. Srikanth, Z. Wang, H. Tu, S. Nair, M. K. Mathew, G. Hasan, and I. Bezprozvanny
Functional Properties of the Drosophila melanogaster Inositol 1,4,5-Trisphosphate Receptor Mutants
Biophys. J., June 1, 2004; 86(6): 3634 - 3646.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. H. George, H. Jundi, N. L. Thomas, M. Scoote, N. Walters, A. J. Williams, and F. A. Lai
Ryanodine Receptor Regulation by Intramolecular Interaction between Cytoplasmic and Transmembrane Domains
Mol. Biol. Cell, June 1, 2004; 15(6): 2627 - 2638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Lee, S.-H. Rho, D. W. Shin, C. Cho, W. J. Park, S. H. Eom, J. Ma, and D. H. Kim
Negatively Charged Amino Acids within the Intraluminal Loop of Ryanodine Receptor Are Involved in the Interaction with Triadin
J. Biol. Chem., February 20, 2004; 279(8): 6994 - 7000.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wang, J. Bolstad, H. Kong, L. Zhang, C. Brown, and S. R. W. Chen
The Predicted TM10 Transmembrane Sequence of the Cardiac Ca2+ Release Channel (Ryanodine Receptor) Is Crucial for Channel Activation and Gating
J. Biol. Chem., January 30, 2004; 279(5): 3635 - 3642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen
Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction
J. Biol. Chem., December 19, 2003; 278(51): 51557 - 51565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. I. Anyatonwu, E. D. Buck, and B. E. Ehrlich
Methanethiosulfonate Ethylammonium Block of Amine Currents through the Ryanodine Receptor Reveals Single Pore Architecture
J. Biol. Chem., November 14, 2003; 278(46): 45528 - 45538.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. B. Romero, N. Monnier, L. Viollet, A. Cortey, M. Chevallay, J. P. Leroy, J. Lunardi, and M. Fardeau
Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia
Brain, November 1, 2003; 126(11): 2341 - 2349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Fessenden, C. F. Perez, S. Goth, I. N. Pessah, and P. D. Allen
Identification of a Key Determinant of Ryanodine Receptor Type 1 Required for Activation by 4-Chloro-m-cresol
J. Biol. Chem., August 1, 2003; 278(31): 28727 - 28735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, Z. Liu, H. Masumiya, R. Wang, D. Jiang, F. Li, T. Wagenknecht, and S. R. W. Chen
Three-dimensional Localization of Divergent Region 3 of the Ryanodine Receptor to the Clamp-shaped Structures Adjacent to the FKBP Binding Sites
J. Biol. Chem., April 11, 2003; 278(16): 14211 - 14218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. R. Bidasee, L. Xu, G. Meissner, and H. R. Besch Jr.
Diketopyridylryanodine Has Three Concentration-dependent Effects on the Cardiac Calcium-release Channel/Ryanodine Receptor
J. Biol. Chem., April 11, 2003; 278(16): 14237 - 14248.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. G. Du, B. Sandhu, V. K. Khanna, X. H. Guo, and D. H. MacLennan
Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1)
PNAS, December 24, 2002; 99(26): 16725 - 16730.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Liu, J. Zhang, P. Li, S. R. W. Chen, and T. Wagenknecht
Three-dimensional Reconstruction of the Recombinant Type 2 Ryanodine Receptor and Localization of Its Divergent Region 1
J. Biol. Chem., November 22, 2002; 277(48): 46712 - 46719.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Xiao, H. Masumiya, D. Jiang, R. Wang, Y. Sei, L. Zhang, T. Murayama, Y. Ogawa, F. A. Lai, T. Wagenknecht, et al.
Isoform-dependent Formation of Heteromeric Ca2+ Release Channels (Ryanodine Receptors)
J. Biol. Chem., October 25, 2002; 277(44): 41778 - 41785.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Fill and J. A. Copello
Ryanodine Receptor Calcium Release Channels
Physiol Rev, October 1, 2002; 82(4): 893 - 922.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. L. Baker, I. I. Serysheva, S. Sencer, Y. Wu, S. J. Ludtke, W. Jiang, S. L. Hamilton, and W. Chiu
The skeletal muscle Ca2+ release channel has an oxidoreductase-like domain
PNAS, September 17, 2002; 99(19): 12155 - 12160.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
P. K. Shah and R. Sowdhamini
Structural understanding of the transmembrane domains of inositol triphosphate receptors and ryanodine receptors towards calcium channeling
Protein Eng. Des. Sel., November 1, 2001; 14(11): 867 - 874.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Masumiya, P. Li, L. Zhang, and S. R. W. Chen
Ryanodine Sensitizes the Ca2+ Release Channel (Ryanodine Receptor) to Ca2+ Activation
J. Biol. Chem., October 19, 2001; 276(43): 39727 - 39735.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Monnier, N. B. Romero, J. Lerale, P. Landrieu, Y. Nivoche, M. Fardeau, and J. Lunardi
Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor
Hum. Mol. Genet., October 1, 2001; 10(22): 2581 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Avila, J. J. O'Brien, and R. T. Dirksen
Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor
PNAS, March 27, 2001; 98(7): 4215 - 4220.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Suko, G. Hellmann, and H. Drobny
Short- and Long-Term Functional Alterations of the Skeletal Muscle Calcium Release Channel (Ryanodine Receptor) by Suramin: Apparent Dissociation of Single Channel Current Recording and [3H]Ryanodine Binding
Mol. Pharmacol., March 1, 2001; 59(3): 543 - 556.
[Abstract] [Full Text]


Home page
CirculationHome page
P. J. Laitinen, K. M. Brown, K. Piippo, H. Swan, J. M. Devaney, B. Brahmbhatt, E. A. Donarum, M. Marino, N. Tiso, M. Viitasalo, et al.
Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia
Circulation, January 30, 2001; 103(4): 485 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. G. Du, V. K. Khanna, and D. H. MacLennan
Mutation of Divergent Region 1 Alters Caffeine and Ca2+ Sensitivity of the Skeletal Muscle Ca2+ Release Channel (Ryanodine Receptor)
J. Biol. Chem., April 14, 2000; 275(16): 11778 - 11783.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.